Nihal Hatipoğlu Selected Research

Nihal Hatipoğlu Research Topics

Disease

6	Insulin Resistance 11/2020 - 01/2010
3	Non-alcoholic Fatty Liver Disease 12/2017 - 07/2014
2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 07/2014
2	Hypoglycemia (Reactive Hypoglycemia) 01/2018 - 09/2010
2	Prostatic Neoplasms (Prostate Cancer) 09/2016 - 07/2015
2	Endometriosis 09/2016 - 07/2015
2	Precocious Puberty 09/2016 - 07/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021
1	Avitaminosis (Vitamin Deficiency) 01/2021
1	Obesity 01/2021
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 11/2020
1	Hypophosphatemic Rickets 01/2020
1	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 01/2020
1	Congenital Abnormalities (Deformity) 01/2020
1	Familial Hypophosphatemia (Phosphate Diabetes) 01/2020
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019
1	Hypopituitarism (Sheehan's Syndrome) 01/2019
1	Pituitary Diseases (Disease, Anterior Pituitary) 01/2019
1	Gestational Weight Gain 11/2018
1	Birth Weight (Birth Weights) 11/2018
1	Hyperglycemia 01/2018
1	Supraventricular Tachycardia 01/2018
1	Glucose Intolerance 01/2018
1	Atherosclerosis 12/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2017
1	Diabetes Complications 12/2017
1	Infertility (Sterility) 09/2016
1	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 09/2016
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 09/2016
1	Leiomyoma (Uterine Fibroids) 07/2015
1	Breast Neoplasms (Breast Cancer) 07/2015
1	Anaphylaxis (Anaphylactic Shock) 07/2015
1	Fatty Liver 06/2015
1	Hyperinsulinism (Hyperinsulinemia) 07/2014
1	Hypertension (High Blood Pressure) 07/2014
1	Dyslipidemias (Dyslipidemia) 07/2014
1	Abdominal Obesity 07/2014
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 09/2010

Drug/Important Bio-Agent (IBA)

4	Insulin (Novolin)FDA Link 01/2021 - 01/2010
4	Glucose (Dextrose)FDA LinkGeneric 11/2020 - 07/2014
3	Blood Glucose (Blood Sugar)IBA 01/2019 - 01/2018
2	Thiamine (Aneurin)FDA Link 01/2021 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 11/2020 - 03/2013
2	Growth Hormone (Somatotropin)IBA 09/2016 - 09/2010
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2016 - 07/2015
1	VitaminsIBA 01/2021
1	MicronutrientsIBA 01/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2021
1	Riboflavin (Vitamin B2)FDA LinkGeneric 01/2021
1	Vitamin E FDA LinkGeneric 01/2021
1	mono-(2-ethylhexyl)phthalateIBA 11/2020
1	phthalic acid (phthalate)IBA 11/2020
1	Diethylhexyl Phthalate (DEHP)IBA 11/2020
1	Endocrine DisruptorsIBA 11/2020
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2020
1	Fibroblast Growth Factor-23IBA 01/2020
1	SaltsIBA 01/2020
1	Phosphates (Orthophosphate)IBA 01/2020
1	GlucokinaseIBA 01/2020
1	Hormones (Hormone)IBA 01/2019
1	MyokinesIBA 11/2018
1	LeptinIBA 11/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	alpha-2-HS-GlycoproteinIBA 12/2017
1	Acetates (Acetic Acid Esters)FDA Link 09/2016
1	Triptorelin Pamoate (Trelstar)FDA Link 09/2016
1	Transaminases (Aminotransferases)IBA 06/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2015
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 06/2015
1	HDL CholesterolIBA 03/2013

Therapy/Procedure

1	Parenteral Infusions 01/2018
1	Glycemic Control 12/2017